An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 2, 1996, Pages 182-186

  Taguchi, Hirokuni ^a   Kinoshita, Ken Ichiro ^b   Takatsuki, Kiyoshi ^c   Tomonaga, Masao ^d   Araki, Koichi ^e   Arima, Naomichi ^f   Ikeda, Shuichi ^g   Uozumi, Koji ^f   Kohno, Hidehisa ^h   Kawano, Fumio ⁱ   Kikuchi, Hiroshi ^j   Takahashi, Hironori ^k   Tamura, Kazuo ^l   Chiyoda, Shin ^m   Tsuda, Hiroyuki ⁿ   Nishimura, Hiromichi ^o   Hosokawa, Takafumi ^p   Matsuzaki, Hiromitsu ^c   Momita, Saburo ^d   Yamada, Osamu ^q   Miyoshi, Isao ^a   more..

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Nagasaki Chuo National Hospital   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g Sasebo Shiritsu Sogo Hospital   (Japan)

^h Uwazima Municipal Hospital   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^j Ooita Medical School

^k Nobeoka Prefectural Hospital   (Japan)

^l MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^m Nagasaki Red Cross Hospital   (Japan)

ⁿ KUMAMOTO CITY HOSPITAL   (Japan)

^o NTT Kyushu Hospital   (Japan)

^p Ooita Prefectural Hospital

^q KAWASAKI MEDICAL SCHOOL   (Japan)

more..

Author keywords

Adult T cell leukemia lymphoma; Chemotherapy; Granulocyte colony stimulating factor

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VINDESINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 1542639509     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199606010-00012     Document Type: Article

References (13)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
2. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-80.
3. The T- and B-cell Malignancy Study Group. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special references to adult T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. Jpn J Clin Oncol 1985;15:517-35.
4. The T- and B-cell Malignancy Study Group. The third nationwide study on adult T-cell leukemia/lymphoma (ATL) in Japan. Characteristic patterns of HLA antigen and HTLV-I infection in ATL patients and their relatives. Int J Cancer 1988;41:505-12.
5. Shimoyama M, Ota K, Kikuchi M, et al. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA of VEPA-M. J Clin Oncol 1988;6:128-41.
6. Lymphoma Study Group. Co-operative clinical studies on adult T-cell leukemia-lymphoma (ATL): a report from the Lymphoma Study Group (1984-1987) on prognostic factors, diagnostic criteria of clinical subtype, clinical features and present status of the treatment of ATL [in Japanese]. Ganno-Rinsyo 1991;37:333-49.
7. Shimoyama M, and members of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. Br J Haematol 1991;79:428-37.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:151-8.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966 ;50:163-70.
10. Gehan E. A generalized Wilcoxon test for comparing arbitrarily singly-censored sample. Biometrika 1965;52:203-23.
11. Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983;52:1986-92.
12. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
13. Shimoyama M. Treatment of patients with adult T-cell leukemia lymphoma: an overview. Gann Monograph 1992;39:43-56.